Affiliation:
1. I.M. Sechenov First Moscow State Medical University (Sechenov University)
2. National Medical Research Center for Preventive Medicine
3. Lomonosov Moscow State University
4. Eramishanzev Moscow City Clinical Hospital
Abstract
The article presents the case report of a rare hereditary form of systemic ATTR-amyloidosis in Russian patient with a discussion of approaches to the diagnosis and treatment of this form, also based on the own experience in the management of such patients. Modern ideas about the pathogenesis of the disease as well as detailed information about the clinical manifestations of amyloid cardiopathy and of other organs are presented. The nature of structural and hemodynamic changes in the heart is discussed on the basis of experience, including own, ultrasound examination of the heart in patients with amyloidosis, especially the article focuses the reader's attention on the true infiltrative nature of transtiretin amyloid cardiopathy in contrast to AL-amyloidosis, in which there is a significant inflammatory component that determines a more unfavorable natural course of AL-amyloidosis of the heart. The article discusses the differential diagnosis of different types of amyloidosis, the diagnostic difficulties associated with weak congophilia of transtiretin amyloidosis and at the same time substantiates the need for morphological verification of the diagnosis. Modern methods of treatment of ATTR-amyloidosis are discussed.
Publisher
Stolichnaya Izdatelskaya Kompaniyaizdat
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine
Reference45 articles.
1. Association of Nephrologists, Scientific Society of Nephrologists of Russia. Diagnosis and treatment of AA- and AL-amyloidosis. Clinical recommendations, 2014. [cited by Jun 06, 2019]. Available from: http://nonr.ru/wp-content/uploads/2013/11/National-Clinical-Recommendations- “Diagnosisand Treatment” AA--AL- amyloidosis “.pdf (In Russ).
2. Wechalekar A.D., Gillmore J.D., Hawkins P.N. Systemicamyloidosis. Lancet. 2016;387(10038):2641-54. DOI:10.1016/S0140-6736(15)01274-X.
3. Kelly J.J., Kyle R.A., O'Brien P.C., et al. The natural history of peripheral neuropathy in primary systemic amyloidosis. Annals of Neurology. 1979;6(1):1-7. DOI:10.1002/ana.410060102.
4. Kyle R., Gertz M. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol.1995;32(1):45-59.
5. Garcia-Pavia P., Comín-Colet J., Barriales-Villa R., et al. Comments on the 2014 ESC Guidelines on the diagnosis and management of hypertrophic cardiomyopathy. A critical view from the perspective of Spanish cardiology. Rev Esp Cardiol. 2015;68:4-9. DOI:10.1016/j.rec.2014.10.011.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献